2025 North America Biobanking Market Revenue Opportunities Report
Description
The 2025 North America Biobanking Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North America biobanking market are BioLife Solutions Inc., Hamilton Company, Sigma-Aldrich Inc. (Merck KGaA), and Thermo Fisher Scientific Inc. These companies provide comprehensive solutions for biobanking, including cryogenic storage systems, laboratory instruments, reagents, and sample management systems essential for the collection, storage, and analysis of biological specimens. Thermo Fisher Scientific, with its global reach and innovation focus, leads in scalable and customizable biobanking solutions, while Merck KGaA offers a broad portfolio supporting sample analytics and storage. BioLife Solutions and Hamilton Company also specialize in cryopreservation and bioprocessing equipment critical to advancing research in regenerative medicine and drug discovery.
North America’s biobanking market is valued at over $1 billion with a robust CAGR above 8%, driven largely by the United States' demand for personalized medicine, genomic research, and pharmaceutical innovations. The key players leverage strong government funding, advanced technology integration such as AI-driven data analysis, and collaborations with academic and healthcare institutions to enhance biobank infrastructure. Sigma-Aldrich, under Merck, and Hamilton contribute significantly to bioprocessing and sample preservation technologies, supporting diverse biobanking applications including stem cell, cord blood, and DNA/RNA banking. These companies enable efficient sample storage and management to accelerate medical research and precision therapy development across North America.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North America biobanking market are BioLife Solutions Inc., Hamilton Company, Sigma-Aldrich Inc. (Merck KGaA), and Thermo Fisher Scientific Inc. These companies provide comprehensive solutions for biobanking, including cryogenic storage systems, laboratory instruments, reagents, and sample management systems essential for the collection, storage, and analysis of biological specimens. Thermo Fisher Scientific, with its global reach and innovation focus, leads in scalable and customizable biobanking solutions, while Merck KGaA offers a broad portfolio supporting sample analytics and storage. BioLife Solutions and Hamilton Company also specialize in cryopreservation and bioprocessing equipment critical to advancing research in regenerative medicine and drug discovery.
North America’s biobanking market is valued at over $1 billion with a robust CAGR above 8%, driven largely by the United States' demand for personalized medicine, genomic research, and pharmaceutical innovations. The key players leverage strong government funding, advanced technology integration such as AI-driven data analysis, and collaborations with academic and healthcare institutions to enhance biobank infrastructure. Sigma-Aldrich, under Merck, and Hamilton contribute significantly to bioprocessing and sample preservation technologies, supporting diverse biobanking applications including stem cell, cord blood, and DNA/RNA banking. These companies enable efficient sample storage and management to accelerate medical research and precision therapy development across North America.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
